The NeuroStar TMS Therapy system was developed by Neuronetics, a privately held medical device company that focuses on developing and commercializing noninvasive therapies to treat chronic psychiatric and neurologic disorders. Learn more about Neuronetics.

* NeuroStar TMS Therapy^® is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode.